This is the latest episode of Chasing Life with Dr. Sanjay Gupta.
The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use and a moderate to low potential for physical and psychological dependence. But what does this mean in the real world exactly?
Sanjay talks with “The Pot Doc” Dr. Staci Gruber, Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program in Boston, to explore the possible impacts of this rescheduling on research, healthcare, and yes – even you.
Peter Goodman: How Cannabis and Opium Poppies Became National Security Issues
This piece is by WWSG exclusive thought leader, Peter Goodman. Never mind that everyone calls him Groovy, or that the company he oversees — Bright…
Thought Leader: Peter Goodman
Dr. Scott Gottlieb on Novo Nodrisk’s oral diabetes drug, future of weight-loss drugs
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss news of Novo Nordisk’s oral diabetes drug cutting heart-related risks in patients, state of…
Thought Leader: Scott Gottlieb
Sanjay Gupta: Why There’s More Hope for Alzheimer’s
For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled…
Thought Leader: Sanjay Gupta
Sanjay Gupta: Can Science and God Coexist?
Thought Leader: Sanjay Gupta
